Your search for psilocybin returned 16 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Your search for psilocybin returned 16 results

Sort Results:

Relevant Recent
News

Researchers Recommend Reclassification of Psilocybin

Currently, psilocybin, a serotonin receptor agonist, is classified as a Schedule I agent as it has not been approved by the Food and Drug Administration (FDA) for any therapeutic use.
MPR Weekly Dose Podcast

MPR Weekly Dose Podcast Episode 100

This week Pfizer seeks Emergency Use Authorization for their COVID-19 oral antiviral; A meta-analysis found commonly prescribed drugs were linked to orthostatic hypotension; A novel treatment is approved for polycythemia vera; A new program has been cleared to allow individuals to carry out remote endoscopy procedures; And the largest to date psilocybin trial shows promise in treatment-resistant depression.